JAN 09, 2021 7:18 AM PST

Automated system provides guidance for cancer patients' symptoms

A new computer system called eRAPID has been debuted in a UK trial to test out how it can assist cancer patients in managing symptoms. The system, designed by the University of Leeds, was developed to offer guidance to cancer patients so as to ameliorate their wellbeing.

The online eHealth system was tested by early-stage colorectal, breast, and gynecological cancer patients who were able to update their symptoms into eRAPID and receive automated severity-dependent advice, which either suggests ways to manage the symptoms or recommends patients to seek medical assistance. Such an automated system is beneficial in that it can decrease clinicians’ workload by answering commonly asked questions without patients requiring direct contact with physicians.

The trial evaluated the impact of the eRAPID system by analyzing how it improved symptom control, healthcare use, patient self-efficacy, and quality of life (QOL). The results showed that patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Overall, patients also reported more confidence in managing their health.

"Rising numbers of cancer patients are receiving a range of anti-cancer treatments which means patients are living longer and require longer periods of care and monitoring,” commented Program lead Professor Galina Velikova, at the Leeds Institute of Medical Research at St James's. "Remote online monitoring options have the potential to be a patient-centered, safe, and effective approach to support patients during cancer treatment and manage the growing clinical workload for cancer care."

Photo: Pexels

Dr. Kate Absolom adds that this trial is extremely needed considering the limitations that the pandemic have put on in-person healthcare: "The encouraging results from this study will help pave the way for future development and refinement of these interventions in broader cancer settings. The COVID19 pandemic highlighted the need and speeded a shift towards technology-enabled care, so these study results are very timely."

It can often be difficult for cancer patients to know what symptoms are normal and expected when undergoing treatment versus what symptoms are dangerous and require medical attention. The trial showed that the electronic system increased patient confidence in managing their mild and moderate treatment-related symptoms and did not compromise patient safety or treatment delivery.

Sources: Journal of Clinical Oncology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
SEP 13, 2021
Cancer
Fat Loss can Predict Gastric Cancer Survival
SEP 13, 2021
Fat Loss can Predict Gastric Cancer Survival
Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cac ...
OCT 04, 2021
Cancer
Predicting Progression-Free Survival in a Melanoma Study
OCT 04, 2021
Predicting Progression-Free Survival in a Melanoma Study
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
Loading Comments...